Overview

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the prostatic diffusion in significant concentration of ertapenem achieved after a pre-operative single administration.
Phase:
Phase 4
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Ertapenem